Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Mind Medicine Inc shares valued at $110,217 were purchased by MARK SULLIVAN on Sep 25 ’25. At $9.77 per share, MARK SULLIVAN acquired 11,278 shares.
Also, DANIEL ROLLINGS KARLIN purchased 7,704 shares, netting a total of over 75,289 in proceeds.
Before that, ROBERT B BARROW had added 25,797 shares to its account. In a trade valued at $252,106, the Officer bought Mind Medicine Inc shares for $9.77 each.
Analysts at Evercore ISI started covering the stock with ‘”an Outperform”‘ outlook in a report released in late January. As of December 20, 2024, Chardan Capital Markets has initiated its “Buy” rating for MNMD.
Analyzing MNMD Stock Performance
On last trading session, Mind Medicine Inc [NASDAQ: MNMD] plunged -0.51% to $9.77. The stock’s lowest price that day was $9.53, but it reached a high of $10.3 in the same session. During the last five days, there has been a surge of approximately 3.06%. Over the course of the year, Mind Medicine Inc shares have jumped approximately 66.44%. Shares of the company reached a 52-week high of $11.02 on 08/25/25 and a 52-week low of $4.70 on 04/09/25.
Support And Resistance Levels for Mind Medicine Inc (MNMD)
According to the 24-hour chart, there is a support level at 9.43, which, if violated, would cause prices to drop to 9.10. In the upper region, resistance lies at 10.20. The next price resistance is at 10.64. RSI (Relative Strength Index) is 53.95 on the 14-day chart, showing neutral technical sentiment.
Is Mind Medicine Inc subject to short interest?
Stocks of Mind Medicine Inc saw a sharp steep in short interest on 2025-08-29 dropping by -0.28 million shares to 10.19 million. Data from Yahoo Finance shows that the short interest on 2025-07-31 was 10.47 million shares. A decline of -2.75% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 8.19 of the overall float, the days-to-cover ratio (short ratio) decline to 8.19.
Which companies own the most shares of Mind Medicine Inc (MNMD)?
In terms of Mind Medicine Inc share price expectations, FactSet research, analysts set an average price target of 18 in the next 12 months, up nearly 83.3% from the previous closing price of $9.82. Analysts anticipate Mind Medicine Inc stock to reach 22 by 2025, with the lowest price target being 14. In spite of this, 2 analysts ranked Mind Medicine Inc stock as Buy at the end of 2025. On July 24, 2024, ROTH MKM assigned a price target of “a Buy” to the stock and initiated coverage with a $36.
